The lipoprotein LipL32, An enigma of leptospiral biology

Veterinary Microbiology

Volumn 162, Issue 2-4, 2013, Pages 305-314

  Murray, Gerald L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adhesin; Immune response; Leptospira; LipL32; Vaccine; Virulence factor

Indexed keywords

LEPTOSPIROSIS VACCINE; OUTER MEMBRANE PROTEIN LIPL32;

BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; HUMAN; IMMUNE RESPONSE; LEPTOSPIRA; LEPTOSPIROSIS; METHYLATION; MUTAGENESIS; NONHUMAN; OSMOLARITY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PSEUDOALTEROMONAS; REVIEW; TH1 CELL; TRANSPOSON; VACCINATION;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; LIPOPROTEINS;

ANIMALIA; LEPTOSPIRA;

EID: 84872486407     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.11.005     Document Type: Review

References (66)

1. Adler B., De la Peña Moctezuma A. Leptospira and leptospirosis. Vet. Microbiol. 2010, 140:287-296.
2. Adler B., Lo M., Seemann T., Murray G.L. Pathogenesis of leptospirosis: the influence of genomics. Vet. Microbiol. 2011, 153:73-81.
3. Branger C., Chatrenet B., Gauvrit A., Aviat F., Aubert A., Bach J.M., Andre-Fontaine G. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect. Immun. 2005, 73:4062-4069.
4. Branger C., Sonrier C., Chatrenet B., Klonjkowski B., Ruvoen-Clouet N., Aubert A., Andre-Fontaine G., Eloit M. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect. Immun. 2001, 69:6831-6838.
5. Cao X.J., Dai J., Xu H., Nie S., Chang X., Hu B.Y., Sheng Q.H., Wang L.S., Ning Z.B., Li Y.X., Guo X.K., Zhao G.P., Zeng R. High-coverage proteome analysis reveals the first insight of protein modification systems in the pathogenic spirochete Leptospira interrogans. Cell Res. 2010, 20:197-210.
6. Cao Y., Faisal S.M., Yan W., Chang Y.C., McDonough S.P., Zhang N., Akey B.L., Chang Y.F. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model. Vaccine 2011, 29:7379-7386.
7. Chaemchuen S., Rungpragayphan S., Poovorawan Y., Patarakul K. Identification of candidate host proteins that interact with LipL32, the major outer membrane protein of pathogenic Leptospira, by random phage display peptide library. Vet. Microbiol. 2011, 153:178-185.
8. Choy H.A., Kelley M.M., Chen T.L., Moller A.K., Matsunaga J., Haake D.A. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun. 2007, 75:2441-2450.
9. Cullen P.A., Cordwell S.J., Bulach D.M., Haake D.A., Adler B. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect. Immun. 2002, 70:2311-2318.
10. Cullen P.A., Xu X., Matsunaga J., Sanchez Y., Ko A.I., Haake D.A., Adler B. Surfaceome of Leptospira spp. Infect. Immun. 2005, 73:4853-4863.
11. Deveson-Lucas D.S., Cullen P.A., Lo M., Srikram A., Sermswan R., Adler B. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 2011, 29:3413-3418.
12. Doherty R.L. A second infection with leptospirosis. Med. J. Aust. 1956, 43:59-60.
13. Donadini R., Fields B.A. Yersinia pseudotuberculosis superantigens. Chem. Immunol. Allergy 2007, 93:77-91.
14. Faine S., Adler B., Bolin C., Perolat P. Leptospira and Leptospirosis 1999, MediSci, Australia.
15. Figueira C.P., Croda J., Choy H.A., Haake D.A., Reis M.G., Ko A.I., Picardeau M. Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin. BMC Microbiol. 2011, 11:129.
16. Flannery B., Costa D., Carvalho F.P., Guerreiro H., Matsunaga J., Da Silva E.D., Ferreira A.G., Riley L.W., Reis M.G., Haake D.A., Ko A.I. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J. Clin. Microbiol. 2001, 39:3303-3310.
17. Grassmann A.A., Felix S.R., Ximendes Dos Santos C., Amaral M.G., Seixas Neto A.C., Fagundes M.Q., Seixas F.K., Da Silva E.F., Conceicao F.R., Dellagostin O.A. Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin. Clin. Vaccine Immunol. 2012, 19:740-745.
18. Guerreiro H., Croda J., Flannery B., Mazel M., Matsunaga J., Galvao Reis M., Levett P.N., Ko A.I., Haake D.A. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect. Immun. 2001, 69:4958-4968.
19. Haake D.A., Chao G., Zuerner R.L., Barnett J.K., Barnett D., Mazel M., Matsunaga J., Levett P.N., Bolin C.A. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect. Immun. 2000, 68:2276-2285.
20. Habarta A., Abreu P.A., Olivera N., Hauk P., Cedola M.T., Ferrer M.F., Ho P.L., Gomez R.M. Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit. Curr. Microbiol. 2011, 62:526-531.
21. Hartskeerl R.A. International Leptospirosis Society: objectives and achievements. Rev. Cubana Med. Trop. 2005, 57:7-10.
22. Hauk P., Barbosa A.S., Ho P.L., Farah C.S. Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen. J. Biol. Chem. 2012, 287:4826-4834.
23. Hauk P., Guzzo C.R., Roman Ramos H., Ho P.L., Farah C.S. Structure and calcium-binding activity of LipL32, the major surface antigen of pathogenic Leptospira sp. J. Mol. Biol. 2009, 390:722-736.
24. Hauk P., Macedo F., Romero E.C., Vasconcellos S.A., de Morais Z.M., Barbosa A.S., Ho P.L. LipL32, the major leptospiral lipoprotein: the C-terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect. Immun. 2008, 76:2642-2650.
25. Hoke D.E., Egan S., Cullen P.A., Adler B. LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect. Immun. 2008, 76:2063-2069.
26. Jost B.H., Adler B., Vinh T., Faine S. A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J. Med. Microbiol. 1986, 22:269-275.
27. Klimpel G.R., Matthias M.A., Vinetz J.M. Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells. J. Immunol. 2003, 171:1447-1455.
28. Lambert A., Picardeau M., Haake D.A., Sermswan R.W., Srikram A., Adler B., Murray G.L. FlaA proteins in Leptospira interrogans are essential for motility and virulence but are not required for formation of the flagellum sheath. Infect. Immun. 2012, 80:2019-2025.
29. Lee S.H., Kim K.A., Park Y.G., Seong I.W., Kim M.J., Lee Y.J. Identification and partial characterization of a novel hemolysin from Leptospira interrogans serovar Lai. Gene 2000, 254:19-28.
30. Levett P.N. Leptospirosis. Clin. Microbiol. Rev. 2001, 14:296-326.
31. Liao S., Sun A., Ojcius D.M., Wu S., Zhao J., Yan J. Inactivation of the fliY gene encoding a flagellar motor switch protein attenuates mobility and virulence of Leptospira interrogans strain Lai. BMC Microbiol. 2009, 9:253.
32. Lo M., Bulach D.M., Powell D.R., Haake D.A., Matsunaga J., Paustian M.L., Zuerner R.L., Adler B. Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays. Infect. Immun. 2006, 74:5848-5859.
33. Lo M., Murray G.L., Khoo C.A., Haake D.A., Zuerner R.L., Adler B. Transcriptional response of Leptospira interrogans to iron limitation and characterization of a PerR homolog. Infect. Immun. 2010, 78:4850-4859.
34. Lottersberger J., Guerrero S.A., Tonarelli G.G., Frank R., Tarabla H., Vanasco N.B. Epitope mapping of pathogenic Leptospira LipL32. Lett. Appl. Microbiol. 2009, 49:641-645.
35. Lourdault K., Cerqueira G.M., Wunder E.A., Picardeau M. Inactivation of clpB in the pathogen Leptospira interrogans reduces virulence and resistance to stress conditions. Infect. Immun. 2011, 79:3711-3717.
36. Luo D., Xue F., Ojcius D.M., Zhao J., Mao Y., Li L., Lin X., Yan J. Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 2010, 28:243-255.
37. Malmstrom J., Beck M., Schmidt A., Lange V., Deutsch E.W., Aebersold R. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 2009, 460:762-765.
38. Maneewatch S., Sakolvaree Y., Saengjaruk P., Srimanote P., Tapchaisri P., Tongtawe P., Klaysing B., Wongratanacheewin S., Chongsa-Nguan M., Chaicumpa W. Monoclonal antibodies to LipL32 protect against heterologous Leptospira spp. challenge. Hybridoma (2005) 2008, 27:453-465.
39. Masuzawa T., Nakamura R., Hashiguchi Y., Shimizu T., Iwamoto Y., Morita T., Yanagihara Y. Immunological reactivity and passive protective activity of monoclonal antibodies against protective antigen (PAg) of Leptospira interrogans serovar Lai. Zentralbl. Bakteriol. 1990, 272:328-336.
40. Matsui M., Soupe M.E., Becam J., Goarant C. Differential in vivo gene expression of major Leptospira proteins in resistant or susceptible animal models. Appl. Environ. Microbiol. 2012, 78:6372-6376.
41. Matsunaga J., Lo M., Bulach D.M., Zuerner R.L., Adler B., Haake D.A. Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect. Immun. 2007, 75:2864-2874.
42. Monahan A.M., Callanan J.J., Nally J.E. Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect. Immun. 2008, 76:4952-4958.
43. Monahan A.M., Callanan J.J., Nally J.E. Review paper: host-pathogen interactions in the kidney during chronic leptospirosis. Vet. Pathol. 2009, 46:792-799.
44. Murray G.L., Srikram A., Henry R., Hartskeerl R.A., Sermswan R.W., Adler B. Mutations affecting Leptospira interrogans lipopolysaccharide attenuate virulence. Mol. Microbiol. 2010, 78:701-709.
45. Murray G.L., Srikram A., Henry R., Puapairoj A., Sermswan R.W., Adler B. Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes Infect. 2009, 11:311-314.
46. Murray G.L., Srikram A., Hoke D.E., Wunder E.A., Henry R., Lo M., Zhang K., Sermswan R.W., Ko A.I., Adler B. Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect. Immun. 2009, 77:952-958.
47. Naiman B.M., Alt D., Bolin C.A., Zuerner R., Baldwin C.L. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect. Immun. 2001, 69:7550-7558.
48. Nally J.E., Monahan A.M., Miller I.S., Bonilla-Santiago R., Souda P., Whitelegge J.P. Comparative proteomic analysis of differentially expressed proteins in the urine of reservoir hosts of leptospirosis. PLoS One 2011, 6:e26046.
49. Nally J.E., Whitelegge J.P., Bassilian S., Blanco D.R., Lovett M.A. Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect. Immun. 2007, 75:766-773.
50. Patarakul K., Lo M., Adler B. Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiol. 2010, 10:31.
51. Ristow P., Bourhy P., Da Cruz McBride F.W., Figueira C.P., Huerre M., Ave P., Girons I.S., Ko A.I., Picardeau M. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog. 2007, 3:e97.
52. Schoone G.J., Everard C.O., Korver H., Carrington D.G., Inniss V.A., Baulu J., Terpstra W.J. An immunoprotective monoclonal antibody directed against Leptospira interrogans serovar Copenhageni. J. Gen. Microbiol. 1989, 135:73-78.
53. Seixas F.K., da Silva E.F., Hartwig D.D., Cerqueira G.M., Amaral M., Fagundes M.Q., Dossa R.G., Dellagostin O.A. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 2007, 26:88-95.
54. Silva E.F., Medeiros M.A., McBride A.J., Matsunaga J., Esteves G.S., Ramos J.G., Santos C.S., Croda J., Homma A., Dellagostin O.A., Haake D.A., Reis M.G., Ko A.I. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007, 25:6277-6286.
55. Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y., Tsukita S. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 1999, 147:195-204.
56. Srikram A., Zhang K., Bartpho T., Lo M., Hoke D.E., Sermswan R.W., Adler B., Murray G.L. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J. Infect. Dis. 2011, 203:870-879.
57. Stevenson B., Choy H.A., Pinne M., Rotondi M.L., Miller M.C., Demoll E., Kraiczy P., Cooley A.E., Creamer T.P., Suchard M.A., Brissette C.A., Verma A., Haake D.A. Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PLoS One 2007, 2:e1188.
58. Tung J.Y., Yang C.W., Chou S.W., Lin C.C., Sun Y.J. Calcium binds to LipL32, a lipoprotein from pathogenic Leptospira, and modulates fibronectin binding. J. Biol. Chem. 2010, 285:3245-3252.
59. van der Zee J.S., van Swieten P., Aalberse R.C. Inhibition of complement activation by IgG4 antibodies. Clin. Exp. Immunol. 1986, 64:415-422.
60. Vieira M.L., Atzingen M.V., Oliveira T.R., Oliveira R., Andrade D.M., Vasconcellos S.A., Nascimento A.L. In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PLoS One 2010, 5:e11259.
61. Vieira M.L., de Morais Z.M., Vasconcellos S.A., Romero E.C., Nascimento A.L. In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb. Pathog. 2011, 51:360-365.
62. Vivian J.P., Beddoe T., McAlister A.D., Wilce M.C., Zaker-Tabrizi L., Troy S., Byres E., Hoke D.E., Cullen P.A., Lo M., Murray G.L., Adler B., Rossjohn J. Crystal structure of LipL32, the most abundant surface protein of pathogenic Leptospira spp. J. Mol. Biol. 2009, 387:1229-1238.
63. Xue F., Dong H., Wu J., Wu Z., Hu W., Sun A., Troxell B., Yang X.F., Yan J. Transcriptional responses of Leptospira interrogans to host innate immunity: significant changes in metabolism, oxygen tolerance, and outer membrane. PLoS Negl. Trop. Dis. 2010, 4:e857.
64. Yang C.W., Hung C.C., Wu M.S., Tian Y.C., Chang C.T., Pan M.J., Vandewalle A. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int. 2006, 69:815-822.
65. Yang C.W., Wu M.S., Pan M.J., Hsieh W.J., Vandewalle A., Huang C.C. The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells. J. Am. Soc. Nephrol. 2002, 13:2037-2045.
66. Zhang L., Zhang C., Ojcius D.M., Sun D., Zhao J., Lin X., Li L., Yan J. The mammalian cell entry (Mce) protein of pathogenic Leptospira species is responsible for RGD motif-dependent infection of cells and animals. Mol. Microbiol. 2012, 83:1006-1023.